Presentation - Cabozantinib Tablets – Global Export Overview


OddwayIcare1

Uploaded on Feb 24, 2026

A comprehensive B2B presentation detailing the clinical attributes, dosage strengths (20 mg, 40 mg, 60 mg), and regulatory approvals for Cabozantinib Tablets. This guide serves as a complete buying resource for tyrosine kinase inhibitors used in the treatment of advanced renal and hepatocellular carcinomas

Comments

                     

Presentation - Cabozantinib Tablets – Global Export Overview

Cabozantinib Tablets Uses, Dosage, Side Effects, and Complete Buying Guide Cabozantinib Tablets: 20 mg, 40 mg, and 60 mg strengths Presented by Oddway International, Wholesale pharmacy. Cabozantini b Tablets Key attributes of Cabozantinib Tablets for global distribution • Molecule: Cabozantinib (S)-malate • Category: Tyrosine kinase inhibitor • Dosage Form: Film-coated tablets • Strengths: 20 mg, 40 mg, 60 mg www.oddwayinternational.c om How It Works: Cabozantinib Tablets For The Tumor Indicated for inhibition of receptor tyrosine kinases www.oddwayinternational.c om Understanding the Strengths of Cabozantinib Key parameters of absorption, distribution, metabolism, and excretion for cabozantinib • Absorption: Rapid oral absorption; Tmax ~2-4 hours • Distribution: High plasma protein binding (~99.7%) • Metabolism: Primarily hepatic via CYP3A4 • Excretion: Fecal and renal routes www.oddwayinternational.c om Who Should Avoid These Cabozantinib OTvaebrvileewt osf r?egulatory approvals and indications for cabozantinib tablets • MHRA (UK): Advanced renal cell carcinoma • FDA (USA): Hepatocellular carcinoma, medullary thyroid cancer • EMA (EU): Advanced renal cell carcinoma, hepatocellular carcinoma • NHRA (UAE): Renal cell carcinoma • Various regions: Indications for renal cell carcinoma and thyroid cancer www.oddwayinternational.c om Dosage Schedule: Cabozantinib Sttanbdalred tdsosing information for Cabozantinib tablets, including adjustments • Cabozantinib 20 mg, 40 mg, and 60 mg tablets dosing schedules • Indicated for adjustments based on hepatic impairment and drug interactions www.oddwayinternational.c om Contraindication s & Precautions Important safety considerations for cabozantinib tablet usage and monitoring • Hypersensitivity to cabozantinib or excipients • Pregnancy and lactation • Monitor for hypertension, hemorrhage, gastrointestinal perforation • Caution in patients with hepatic impairment www.oddwayinternational.c om Storage Conditions of Cabozantinib tablets Essential requirements for the safe storage of cabozantinib tablets • Storage Temperature: 20-25 °C • Agitation Requirements: [DATA NOT SPECIFIED] • Incoterms®: FOB, CIF, or as contractually agreed www.oddwayinternational.c om Contact UFosr inquiries related to B2B pharmaceutical wholesale of CaPbhonzea:n +t9i1n-9ib87 3T3a3b64le44ts. Email: [email protected] Website: www.oddwayinternational.com Medical Disclaimer Professional Use Only – Not for Self-Medication. The information provided is intended strictly for healthcare professionals (HCPs) and authorized pharmaceutical distributors. This document does not constitute medical advice. All regional regulatory guidelines must be followed. Oddway International | Pharmaceutical Export Division